Abiopharma

The Lovesac Company Expands Share Repurchase Authorization by $40 Million

Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain

FDA Approval of its Plasma Collection Center in San Antonio, Texas

Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain

Nearly One in Three Gen Z Adults Report Not Filing Taxes as Digital Divide Widens Across Generations, ACI Worldwide Survey Finds

Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis

Buda Juice Reports Full Year Fiscal 2025 Financial Results

Sportradar Expands Partnership with Hard Rock Bet, Adding Official Data from the PGA TOUR and Ultimate Fighting Championship

Visa Launches Enhanced Subscription Manager, Giving Consumers Greater Control Over Recurring Payments

Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer